Better than expected > keep in the bottom drawer for another 2years...
Highlights/ take aways
Quarterly cash receipts of A$4,028,000 representing a 57.6% increase on the previous quarter
Strong sales across the group, particularly in Australia and the UK
Acquisitive expansion: Health House’s Board, management team and advisors have a proven track record of identifying and implementing strategic acquisitions and successfully integrating these into existing businesses. Health House believes that it continues to be well placed to attract and identify potential acquisition targets in strategic markets to build out its business and expand its geographic distribution footprint.
Health House International ́s CEO, Mr David Atwood commented: "We are extremely pleased with our results this quarter, we saw a 57.6% increase in cash receipts which exceeded A$4 million for the first time. We also saw an increase in our drawn down debtor financing facility and a small increase in receivables. The team have worked tirelessly in driving the growth in sales in the UK and Australian businesses. In particular, the Australian operations successfully took advantage of regulatory changes and momentum in the Australian medicinal cannabis sector."
gltah
HHI Price at posting:
7.0¢ Sentiment: Buy Disclosure: Held
